martes, 5 de julio de 2016

National Guideline Clearinghouse | Systemic treatment of acute myeloid leukemia (AML).

National Guideline Clearinghouse | Systemic treatment of acute myeloid leukemia (AML).



National Guideline Clearinghouse (NGC)

Program in Evidence-based Care
Guideline Title
Systemic treatment of acute myeloid leukemia (AML).
Bibliographic Source(s)
Schuh AC, Fletcher GG, Leber B, Sabloff M, members of the Hematology Disease Site Group. Systemic treatment of acute myeloid leukemia (AML). Toronto (ON): Cancer Care Ontario (CCO); 2016 Feb 2. 245 p. (Program in Evidence-based Care (PEBC) Guideline; no. 12-9).  [393 references]
Guideline Status
This is the current release of the guideline.
The Program in Evidence-based Care (PEBC) Guideline over time will expand to contain new information emerging from their reviewing and updating activities.
Please visit the Cancer Care Ontario (CCO) Web site External Web Site Policy for details on any new evidence that has emerged and implications to the guidelines.
This guideline meets NGC's 2013 (revised) inclusion criteria.

No hay comentarios:

Publicar un comentario